Welcome to LookChem.com Sign In|Join Free

CAS

  • or

137975-18-9

(4-AMINOPHENYL)[3,4-DIHYDRO-1(2H)-QUINOLINYL]-METHANONE, also known as DHAQD, is a quinoline-based chemical compound with potential pharmaceutical properties. It has been studied for its anti-cancer and anti-inflammatory effects, exhibiting cytotoxicity against cancer cells and inhibiting tumor growth. DHAQD also shows promise in treating inflammatory conditions due to its anti-inflammatory properties.

137975-18-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 137975-18-9 Structure

  • Basic information

    1. Product Name: (4-AMINOPHENYL)[3,4-DIHYDRO-1(2H)-QUINOLINYL]-METHANONE
    2. Synonyms: (4-AMINOPHENYL)[3,4-DIHYDRO-1(2H)-QUINOLINYL]-METHANONE;4-(3,4-dihydro-1(2H)-quinolinylcarbonyl)aniline;(4-aminophenyl)(3,4-dihydroquinolin-1(2H)-yl)methanone
    3. CAS NO:137975-18-9
    4. Molecular Formula: C16H16N2O
    5. Molecular Weight: 252.31104
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 137975-18-9.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: (4-AMINOPHENYL)[3,4-DIHYDRO-1(2H)-QUINOLINYL]-METHANONE(CAS DataBase Reference)
    10. NIST Chemistry Reference: (4-AMINOPHENYL)[3,4-DIHYDRO-1(2H)-QUINOLINYL]-METHANONE(137975-18-9)
    11. EPA Substance Registry System: (4-AMINOPHENYL)[3,4-DIHYDRO-1(2H)-QUINOLINYL]-METHANONE(137975-18-9)

  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 137975-18-9(Hazardous Substances Data)

137975-18-9 Usage

Uses

Used in Oncology:
DHAQD is used as an anti-cancer agent for its cytotoxic effects on cancer cells, which can help inhibit tumor growth. It has been studied for its potential use in treating various types of cancer.
Used in Inflammation Treatment:
DHAQD is used as an anti-inflammatory agent for its ability to reduce inflammation. It has been investigated for its potential in treating various inflammatory conditions, offering a promising therapeutic option for patients suffering from such ailments.

Check Digit Verification of cas no

The CAS Registry Mumber 137975-18-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,7,9,7 and 5 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 137975-18:
(8*1)+(7*3)+(6*7)+(5*9)+(4*7)+(3*5)+(2*1)+(1*8)=169
169 % 10 = 9
So 137975-18-9 is a valid CAS Registry Number.

137975-18-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (4-aminophenyl)-(3,4-dihydro-2H-quinolin-1-yl)methanone

1.2 Other means of identification

Product number -
Other names 4-aminophenyl 1,2,3,4-tetrahydroquinolyl ketone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:137975-18-9 SDS

137975-18-9Downstream Products

137975-18-9Relevant articles and documents

Synthesis and characterization of orally active nonpeptide vasopressin V2 receptor antagonists

Ohkawa, Takehiko,Zenkoh, Tatsuya,Tomita, Masayuki,Hosogai, Naomi,Hemmi, Keiji,Tanaka, Hirokazu,Setoi, Hiroyuki

, p. 501 - 510 (2007/10/03)

The present study was undertaken to evaluate whether a novel series of 2,6-diaza-5-oxobicyclo[5.4.0]undeca-1(7),8,10-triene derivatives exhibited antagonistic activity for vasopressin V1 and V2 receptors. Most of these compounds were

Orally active, nonpeptide vasopressin V2 receptor antagonists: A novel series of 1-[4-(benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepines and related compounds

Ogawa, Hidenori,Yamashita, Hiroshi,Kondo, Kazumi,Yamamura, Yoshitaka,Miyamoto, Hisashi,Kan, Keizo,Kitano, Kazuyoshi,Tanaka, Michinori,Nakaya, Kenji,Nakamura, Shigeki,Mori, Toyoki,Tominaga, Michiaki,Yabuuchi, Youichi

, p. 3547 - 3555 (2007/10/03)

This paper describes a novel series of nonpeptide vasopressin V2 receptor antagonists. It has been demonstrated that the 1-[4- (benzoylamino)benzoyl]-2,3,4,5-1H-benzazepines and 1-[4- (benzoylamino)benzoyl]-2,3,4,5-1H-1,5-benzodiazepines show a high affinity for V2 (and V(1a)) receptors. Among the 1-[4-(benzoylamino)benzoyl]-2,3,4,5- 1H-benzazepine series, compounds with an alkylamino group on the benzazepine ring have been shown to have oral activity. A lipophilic group at the ortho position on the terminal benzoyl ring is important for both high V2 receptor affinity and oral activity. On the basis of these favorable properties, clinical testing of 31b has begun for use as an oral and iv aquaretic agent.

BENZOHETEROCYCLIC COMPOUNDS

-

, (2008/06/13)

Novel benzoheterocyclic compounds of the formula: STR1 wherein R. sup.1 is H, halogen, alkyl, optionally substituted amino, alkoxy; R 2 is H, halogen, alkoxy, phenyialkoxy, OH, alkyl, optionally substituted amino, carbamoyl-alkoxy, optionally substituted

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 137975-18-9